12.21 0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83

1.27 N/A 0.58% 0.00% Distribution costs (41.75 ) (24.14 ) (17.61 ) 72.95% (19.11%) (13.74%) Administrative expenses (95.74 ) (94.34 ) (1.40 ) 1.48% (43.82%) (53.71%) Other Expenses Impairment loss of

sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the

0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83

(TH)") which the Company holds the company’s share for the proportion of 60%. The company had income from service and gross profit increased from last year by 35.36 million baht and 1.16 million baht

service Selling and distribution expenses in Q2-2023 increased from Q2-2022 in the amount of 16.9 million baht, or an increase of 26.2%, mainly because in 2023, some employees from the Service department

(Million Baht: MB) (MB) % (MB) % Revenue from Sales and Service 2,179.9 1,137.4 1,745.2 1,042.5 91.7 434.7 24.9 Cost of Sales and Service 1,820.0 909.4 1,516.0 910.6 100.1 304.0 20.1 Selling and distribution

selling and administrative expenses 114,629 96,763 17,866 18.5 113,022 94,348 18,674 19.8 Selling and distribution expenses 27,060 25,061 1,999 8.0 24,468 22,708 1,760 7.8 Administrative expenses 44,206

engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis services

same period previous year is decrease of Baht 30.90 million or 66.04% due to the company recognized the share of loss from investment in an associated company in the amount of Baht 33.08 million. The